ThermaSolutions​ Announces FDA Approval of HurriChem™

 // News

January 27  

Aerosolizing laparoscopic irrigator is first in U.S.

White Bear Lake, MN; January 27, 2023​ — ​ThermaSolutions​ announces immediate availability of the HurriChem™ Device Kit in the United States as a new tool for laparoscopic irrigation, utilizing aerosolization of liquid into the abdomen. 

The HurriChem Device Kit contains a stainless-steel wand and braided polyurethane tubing. It is a single-use device intended to deliver irrigation fluids to surgical sites during laparoscopic procedures. HurriChem can be inserted via a 10 mm trocar and is designed to be connected to a standard injector pump system.

“It is exciting to be the first tool to market in the United States for laparoscopic irrigation using aerosolization of liquids into the abdomen,” says Gregg Giza, Global Product Director  ​at​ ThermaSolutions​.

​​HurriChem has been in use internationally for over a year in Europe by renown physicians in cancer treatment centers such as the Catharina Cancer Institute in The Netherlands and the Institute Gustave-Roussy in France.

​​With FDA approval in 1999, ​ThermaSolutions​ has become the worldwide leader in peritoneal cancer treatment using HIPEC (Hyperthermic Intraperitoneal Chemotherapy) with the ThermoChem HT-2000 device.

For more information:

Dean Wennerberg      


[email protected]

For more information on HurriChem and other ThermaSolutions products:

Success message!
Warning message!
Error message!